NeuroPace, Inc. NPCE
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 3.43% | -17.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.43% | -17.00% | |||
| Cost of Revenue | -2.49% | -33.11% | |||
| Gross Profit | 4.75% | -12.29% | |||
| SG&A Expenses | 4.41% | 7.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.20% | -2.54% | |||
| Operating Income | 7.63% | -215.11% | |||
| Income Before Tax | 7.31% | -145.11% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 7.31% | -145.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.31% | -145.11% | |||
| EBIT | 7.63% | -215.11% | |||
| EBITDA | 7.82% | -226.50% | |||
| EPS Basic | 8.37% | -142.84% | |||
| Normalized Basic EPS | 8.39% | -138.92% | |||
| EPS Diluted | 8.37% | -142.84% | |||
| Normalized Diluted EPS | 8.39% | -138.92% | |||
| Average Basic Shares Outstanding | 1.15% | 0.99% | |||
| Average Diluted Shares Outstanding | 1.15% | 0.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||